Calibration and discrimination ability of the Dat'AIDS score in people living with HIV aged 70 years and older from the Dat'AIDS cohort.

OBJECTIVE The Dat'AIDS score was developed to predict 5-year mortality risk in people living with HIV aged 60 and older. However, its validity in people living with HIV aged 70 years and older needed confirmation. METHODS This was a multicentre prospective cohort study in the Dat'AIDS French cohort. We calculated the Dat'AIDS score and Veterans Aging Cohort Study (VACS) indices 1.0 and 2.0 in people living with HIV aged 70 or older, at their first medical visit between 01/06/2014 and 31/12/2017. Participants were followed until 31 December 2019 (before the COVID-19 era). Discrimination and calibration of the Dat'AIDS score were assessed using Harrell's C-statistic and comparisons of predicted versus observed survival probabilities. The comparison of the discriminative capacity of the Dat'AIDS score with the VACS indices was performed. RESULTS A total of 1330 participants (75.5% male, median age: 73.7 years, median time since HIV diagnosis: 21.7 years, median time under combination antiretroviral therapy (cART): 19.9 years, median CD4 cell count: 553 cells/μL, HIV-1 RNA ≤50 copies/mL: 88.7%) were included. Overall, 221 (16.6%) deaths were recorded during 5598 patient-years of follow-up. The Dat'AIDS score showed good discrimination (C-statistic: 0.72; 95% confidence interval [CI; 0.68-0.75]). Calibration was good except for the moderate-risk group (5% difference). The Dat'AIDS score showed better discrimination than VACS 1.0 and 2.0 with albumin, aspartate aminotransferase (AST) and alanine transaminase (ALT) normal value imputation (C-statistic: 0.72 vs. 0.69 for both) and was similar to VACS 2.0 without imputation (0.72 vs. 0.71), that could be calculated in 99.1%, 98.6% and 34.0%, respectively. CONCLUSIONS The Dat'AIDS score showed good discrimination and calibration in people living with HIV aged 70 years and older, providing an easy and valuable tool for clinical decision-making and research.

• Publication year

  2026

• Venue

  HIV Medicine

• Publication date

  2026-02-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hiv.70207PMID 41673495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration

  2024cited by this paper
• External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older

  2023cited by this paper
• Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models

  2022cited by this paper
• Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

  2019cited by this paper
• Welcome to the Tidyverse

  2019cited by this paper
• Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals

  2019cited by this paper
• Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score

  2018cited by this paper
• Assessing calibration of prognostic risk scores

  2016cited by this paper
• The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants

  2016cited by this paper
• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

  2015cited by this paper
• Future challenges for clinical care of an ageing population infected with HIV: a modelling study

  2015cited by this paper
• Sample size considerations for the external validation of a multivariable prognostic model: a resampling study

  2015cited by this paper
• Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era — Role of chronic renal disease

  2015cited by this paper
• Demographics of HIV and aging.

  2014cited by this paper
• Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

  2014cited by this paper
• Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

  2014cited by this paper
• HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group

  2012cited by this paper
• Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

  2011cited by this paper
• Premature age-related comorbidities among HIV-infected persons compared with the general population.

  2011cited by this paper
• Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers

  2010cited by this paper
• Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

  2009cited by this paper
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005cited by this paper
• Using Risk for Advanced Proximal Colonic Neoplasia To Tailor Endoscopic Screening for Colorectal Cancer

  2003cited by this paper
• Applied Survival Analysis

  1999cited by this paper
• Applied Logistic Regression, Second Edition

  1989cited by this paper

• No citing papers are available for this paper.